Physician profile
T Eric White
NPI 1235121104
$5,515.83
in general payments reported to CMS, 2019-2025
19 companies · $351 in 2025
The $351 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,086 · 2020: $11.85 · 2021: $911 · 2022: $996 · 2023: $832 · 2024: $326 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,140.75 | 2019-2025 | Triclip |
| Janssen Pharmaceuticals, INC | $1,090.80 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $722.08 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $305.92 | 2022-2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $255.13 | 2021-2025 | Sapien 3 Ultra Resilia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $196.82 | 2021-2024 | Jardiance |
| Boston Scientific Corporation | $196.35 | 2019-2022 | |
| Amgen INC. | $172.38 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $113.48 | 2019-2024 | |
| Surmodics, INC. | $74.16 | 2023-2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Astrazeneca Pharmaceuticals Lp | $52.37 | 2022-2023 | Brilinta |
| Esperion Therapeutics, INC. | $41.02 | 2021-2022 | |
| Stryker Corporation | $34.96 | 2025 | Artix Mt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.74 | 2023 | Lifevest |
| Merck Sharp & Dohme LLC | $24.63 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $22.92 | 2023 | |
| Medtronic, INC. | $18.83 | 2021 | |
| Pfizer INC. | $13.64 | 2023 | |
| Amarin Pharma, INC. | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw T White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.